Tech Center 1600 • Art Units: 1600 1636 1643 1683
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19018456 | METHODS FOR EARLY DETECTION OF CANCER | Final Rejection | GUARDANT HEALTH, INC. |
| 17938273 | MULTIPLEXED SIGNAL AMPLIFICATION | Non-Final OA | President and Fellows of Harvard College |
| 17891641 | METHODS FOR DETERMINING A LOCATION OF AN ANALYTE IN A BIOLOGICAL SAMPLE | Non-Final OA | 10x Genomics, Inc. |
| 17517287 | PARTITIONING AND PROCESSING OF ANALYTES AND OTHER SPECIES | Non-Final OA | 10x Genomics, Inc. |
| 17523489 | METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND COMPOSITIONS RELATED THERETO | Non-Final OA | The Johns Hopkins University |
| 17968446 | SENSOR FOR SIMULTANEOUS CHEMICAL, BIOLOGICAL, AND RADIOLOGICAL/NUCLEAR DETECTION | Non-Final OA | BATTELLE SAVANNAH RIVER ALLIANCE, LLC |
| 18943512 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | Final Rejection | Exact Sciences Corporation |
| 17999154 | EFFICIENT ANTIBODY DNA-BARCODING REAGENTS FOR MULTIPLEXED MOLECULAR IMAGING | Non-Final OA | The Chinese University of Hong Kong |
| 17835719 | Methods for Purification of Messenger RNA | Final Rejection | Translate Bio, Inc. |
| 17930815 | MEMBRANE-SPANNING NANOPORES | Non-Final OA | UCL BUSINESS LTD |
| 16964062 | COMBINATION THERAPEUTICS | Non-Final OA | UCL BUSINESS LTD |
| 17672004 | USE OF 12-LIPOXYGENASE INHIBITORS IN THE TREATMENT OF COVID-19 | Final Rejection | New York Medical College |
| 17968155 | DIAGNOSTIC APPLICATIONS USING NUCLEIC ACID FRAGMENTS | Non-Final OA | GRAIL, Inc. |
| 17989925 | NUCLEIC ACID SECURITY AND AUTHENTICATION | Non-Final OA | CATALOG TECHNOLOGIES, INC. |
| 17937724 | COLOCALIZATION-BY-LINKAGE SANDWICH ASSAYS | Non-Final OA | Nomic Bio Inc. |
| 17856072 | METHODS FOR SELECTIVELY SUPPRESSING NON-TARGET SEQUENCES | Non-Final OA | Molecular Loop Biosciences, Inc. |
| 17750567 | METHODS OF PERFORMING NUCLEIC ACID STABILIZATION AND SEPARATION | Non-Final OA | QVELLA CORPORTATION |
| 17309424 | SECURITY MARKERS | Final Rejection | CRIME SOLUTIONS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy